atropine + remifentanil

The combination of atropine and remifentanil represents a specific anesthetic regimen used primarily in surgical settings. ## Description Atropine combined with remifentanil is an anesthetic regimen used primarily during surgical procedures, particularly in pediatric patients. This combination offers several clinical advantages over remifentanil monotherapy. Atropine, an anticholinergic agent, works synergistically with remifentanil, an ultra short-acting synthetic opioid, to provide optimal intubation conditions and reduce potential negative hemodynamic effects of anesthesia induction. Clinical studies have shown that atropine combined with remifentanil exhibits better anesthetic effects than remifentanil alone, with a lower incidence of adverse events, fewer influences on hemodynamics, milder stress responses, and faster recovery from anesthesia. The prophylactic administration of atropine can compensate for the reduction in cardiac output in cases pre-administered with remifentanil, preventing the prolongation of rocuronium onset time and reducing the time to tracheal intubation. ## Pharmacology Remifentanil is a potent μ-opioid receptor agonist with rapid onset (1-2 minutes) and an ultra-short duration of action due to its unique metabolism by non-specific plasma and tissue esterases. Its elimination half-life is 3-10 minutes, making it ideal for procedures requiring rapid titration and recovery. Atropine is an anticholinergic agent that blocks muscarinic effects and can prevent the bradycardia and hypotension commonly associated with remifentanil administration. When used together, atropine can attenuate the sympatholytic effects of remifentanil, maintaining better hemodynamic stability during anesthesia. ## Clinical Applications This combination is particularly valuable in: - Pediatric acute appendicitis surgery - Procedures requiring rapid tracheal intubation - General anesthesia where hemodynamic stability is crucial - Situations where rapid recovery from anesthesia is desired ## Side Effects Common side effects of this combination include: - Muscle rigidity (6-7%) at induction - Hypotension (3-5%) and bradycardia (1-4%) intraoperatively - Shivering (6-7%), nausea and vomiting postoperatively The combination with atropine helps mitigate some of the cardiovascular side effects commonly seen with remifentanil alone, such as bradycardia and hypotension. ## Dosage Dosage depends on clinical experience, user preference, and patient/operative factors. Remifentanil is typically administered as a continuous infusion, while atropine is often given as a prophylactic dose (e.g., 0.5 mg) before remifentanil administration.